Diagnosis of vaginitis

American Family Physician

Volumn 62, Issue 5, 2000, Pages 1095-1104

  Egan, Mari E ^a   Lipsky, Martin S ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BORIC ACID; BUTOCONAZOLE; CLINDAMYCIN; CLINDAMYCIN PHOSPHATE; CLOTRIMAZOLE; FLUCONAZOLE; KETOCONAZOLE; METRONIDAZOLE; MICONAZOLE; NYSTATIN; TERCONAZOLE; TIOCONAZOLE;

ALGORITHM; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; LABORATORY DIAGNOSIS; PATHOPHYSIOLOGY; PREVALENCE; REVIEW; TRICHOMONIASIS; VAGINA CANDIDIASIS; VAGINA DISCHARGE; VAGINITIS;

ANTIFUNGAL AGENTS; CANDIDIASIS; DECISION TREES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; TRICHOMONAS VAGINITIS; VAGINITIS; VAGINOSIS, BACTERIAL; VULVOVAGINITIS;

EID: 0034283269     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. Epidemiology of vaginitis
2. Evaluation and management of vaginitis. An update for primary care practitioners
3. Evaluation and management of vaginitis
4. Vulvovaginitis in healthy women
5. Current evaluation and management of vulvovaginitis
6. Advances in diagnostic testing for vaginitis and cervicitis
7. The limited value of symptoms and signs in the diagnosis of vaginal infections
8. Vaginitis
9. Establishing the cause of genitourinary symptoms in women in a family practice. Comparison of clinical examination and comprehensive microbiology
10. Evolving pathogens in vulvovaginal candidiasis: Implications for patient care
11. The microbiology of bacterial vaginosis
12. Recurrent bacterial vaginosis
13. Bacterial vaginosis
14. Nonspecific vaginitis and other genital infections in three clinic populations
15. Bacterial vaginosis in virginal and sexually active adolescent females: Evidence against exclusive sexual transmission
16. A follow-up study of methods of contraception, sexual activity, and rates of trichomoniasis, candidiasis, and bacterial vaginosis
17. Bacterial flora of the cervix in women using different methods of contraception
18. Abnormal bacterial colonisation of the genital tract and subsequent preterm delivery and late miscarriage
19. Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group
20. Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis
21. Classification and pathogenesis of vulvovaginal candidiasis
22. Value of wet mount and cervical cultures at the time of cervical cytology in asymptomatic women
23. Observations concerning the microbial etiology of acute salpingitis
24. Plasma cell endometritis in women with symptomatic bacterial vaginosis
25. The epidemiology of vulvovaginal candidiasis: Risk factors
26. Candidal vulvovaginitis
27. Risk factors for vulvovaginal candidiasis: A case-control study among university students
28. Vulvovaginal candidiasis: Epidemiologic, diagnostic, and therapeutic considerations
29. The impact of oral contraception on vulvovaginal candidiasis
30. Effects of recent sexual activity and use of a diaphragm on the vaginal microflora
31. A case-controlled study of the sexual health needs of lesbians
32. Vulvovaginal candidiasis: Clinical manifestations, risk factors, management algorithm
33. Effect of antibiotic use on the prevalence of symptomatic vulvovaginal candidiasis
34. Epidemiology and outcomes associated with moderate to heavy Candida colonization during pregnancy. Vaginal Infections and Prematurity Study Group
35. Vulvar vestibulitis syndrome: An often unrecognized cause of dyspareunia
36. 1998 Guidelines for treatment of sexually transmitted diseases. Centers for Disease Control and Prevention
37. Pathogenesis and treatment of recurrent vulvovaginal candidiasis
38. Trichomoniasis: Trends in diagnosis and management
39. Clinical and microbiological aspects of Trichomonas vaginalis
40. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: Results from a cohort study
41. Demographic and behavioral predictors of Trichomonas vaginalis infection among pregnant women. The Vaginal Infections and Prematurity Study Group
42. Trichomonas vaginalis
43. Criteria for selective screening for Chlamydia trachomatis infection in women attending family planning clinics
44. Diagnosis of trichomoniasis. Comparison of conventional wet-mount examination with cytologic studies, cultures, and monoclonal antibody staining of direct specimens
45. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations
46. Statistical evaluation of diagnostic criteria for bacterial vaginosis
47. Comparison of methods for diagnosing bacterial vaginosis among pregnant women
48. Vaginitis
49. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of Gram stain interpretation
50. Diagnosis of bacterial vaginosis by direct Gram stain of vaginal fluid
51. Reproducibility of interpretation of Gram-stained vaginal smears for the diagnosis of bacterial vaginosis
52. Pathophysiology of vulvovaginal candidiasis
53. Evaluation of a deoxyribonucleic acid probe for the detection of Trichomonas vaginalis in vaginal secretions
54. Bacterial vaginosis: Review of treatment options and potential clinical indications for therapy
55. Antifungal agents vs. boric acid for treating chronic mycotic vulvovaginitis